William R. Kirkpatrick

6.0k total citations · 1 hit paper
74 papers, 4.7k citations indexed

About

William R. Kirkpatrick is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William R. Kirkpatrick has authored 74 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Infectious Diseases, 59 papers in Epidemiology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William R. Kirkpatrick's work include Antifungal resistance and susceptibility (70 papers), Fungal Infections and Studies (50 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). William R. Kirkpatrick is often cited by papers focused on Antifungal resistance and susceptibility (70 papers), Fungal Infections and Studies (50 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). William R. Kirkpatrick collaborates with scholars based in United States, United Kingdom and Japan. William R. Kirkpatrick's co-authors include Thomas F. Patterson, Michael G. Rinaldi, Annette W. Fothergill, Robert K. McAtee, José L. López-Ribot, Sofía Perea, Laura K. Najvar, Spencer W. Redding, Roberts A. Smith and John R. Graybill and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

William R. Kirkpatrick

74 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

2000 576 citations Thomas F. Patterson, William R. Kirkpatrick et al. Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William R. Kirkpatrick United States	36	3.8k	2.9k	585	479	458	74	4.7k
Alessandro C. Pasqualotto Brazil	39	3.5k 0.9×	2.8k 0.9×	514 0.9×	480 1.0×	758 1.7×	167	5.0k
Jesús Guinea Spain	41	4.9k 1.3×	3.9k 1.3×	555 0.9×	523 1.1×	404 0.9×	204	5.9k
J. L. Rodríguez-Tudela Spain	33	3.5k 0.9×	2.7k 0.9×	410 0.7×	462 1.0×	659 1.4×	58	4.5k
J N Galgiani United States	36	3.3k 0.9×	2.9k 1.0×	420 0.7×	383 0.8×	397 0.9×	71	4.5k
Vidmantas Petraitis United States	34	3.3k 0.9×	2.5k 0.8×	332 0.6×	593 1.2×	265 0.6×	110	3.9k
Tin Sein United States	31	4.4k 1.1×	3.4k 1.2×	325 0.6×	721 1.5×	286 0.6×	54	5.0k
Joseph Meletiadis Greece	40	3.8k 1.0×	3.2k 1.1×	701 1.2×	830 1.7×	601 1.3×	194	5.8k
Shivaprakash M. Rudramurthy India	42	4.8k 1.3×	3.9k 1.3×	519 0.9×	656 1.4×	500 1.1×	300	6.9k
Rūta Petraitienė United States	36	3.4k 0.9×	2.7k 0.9×	292 0.5×	667 1.4×	278 0.6×	108	4.1k
Aristea Velegraki Greece	38	2.2k 0.6×	2.8k 0.9×	638 1.1×	216 0.5×	576 1.3×	131	5.0k

Countries citing papers authored by William R. Kirkpatrick

Since Specialization

Citations

This map shows the geographic impact of William R. Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Kirkpatrick more than expected).

Fields of papers citing papers by William R. Kirkpatrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Kirkpatrick. The network helps show where William R. Kirkpatrick may publish in the future.

Co-authorship network of co-authors of William R. Kirkpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Kirkpatrick. A scholar is included among the top collaborators of William R. Kirkpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Kirkpatrick. William R. Kirkpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, Douglas S., Laura K. Najvar, Nathan P. Wiederhold, et al.. (2013). Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosis. Medical Mycology. 51(6). 592–602. 6 indexed citations

Kirkpatrick, William R., Laura K. Najvar, Ana C. Vallor, et al.. (2012). Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. Journal of Antimicrobial Chemotherapy. 67(4). 970–976. 20 indexed citations

Thompson, George R., Nathan P. Wiederhold, Laura K. Najvar, et al.. (2012). A murine model of Cryptococcus gattii meningoencephalitis. Journal of Antimicrobial Chemotherapy. 67(6). 1432–1438. 24 indexed citations

Wiederhold, Nathan P., Laura K. Najvar, Rosie Bocanegra, William R. Kirkpatrick, & Thomas F. Patterson. (2011). Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis. Clinical Microbiology and Infection. 18(2). E20–E23. 20 indexed citations

McCulloch, Elaine, Gordon Ramage, Ranjith Rajendran, et al.. (2011). Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. Journal of Clinical Pathology. 65(1). 83–86. 41 indexed citations

Redding, Spencer W., et al.. (2010). Recovery of Candida dubliniensis and other Candida species from the oral cavity of subjects with periodontitis who had well-controlled and poorly controlled type 2 diabetes: a pilot study. Special Care in Dentistry. 30(6). 230–234. 21 indexed citations

Kirkpatrick, William R., Michael Bröker, Annette W. Fothergill, et al.. (2010). Screening for drug-resistantCandidayeasts with chromogenic agar. Medical Mycology. 48(6). 807–816. 3 indexed citations

Thompson, George R., et al.. (2010). Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 109(4). 488–495. 123 indexed citations

Oliveira, Érica Rodrigues de, Annette W. Fothergill, William R. Kirkpatrick, Thomas F. Patterson, & Spencer W. Redding. (2008). Antifungal susceptibility testing of micafungin against Candida glabrata isolates. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 105(4). 457–459. 5 indexed citations

10.

Kirkpatrick, William R., César O. Freytes, Juan J. Toro, et al.. (2007). Candida kruseisepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient. Medical Mycology. 45(2). 187–190. 26 indexed citations

11.

Cramer, Robert A., Michael P. Gamcsik, Laura K. Najvar, et al.. (2006). Disruption of a Nonribosomal Peptide Synthetase in Aspergillus fumigatus Eliminates Gliotoxin Production. Eukaryotic Cell. 5(6). 972–980. 168 indexed citations

12.

Redding, Spencer W., William R. Kirkpatrick, Brent J. Coco, et al.. (2004). Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 97(1). 47–52. 72 indexed citations

13.

Viudes, A, Anna L. Lazzell, Sofía Perea, et al.. (2004). The C-terminal antibody binding domain ofCandida albicansmp58 represents a protective epitope during candidiasis. FEMS Microbiology Letters. 232(2). 133–138. 25 indexed citations

14.

Kirkpatrick, William R.. (2002). Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis. Journal of Antimicrobial Chemotherapy. 49(2). 353–357. 28 indexed citations

15.

Redding, Spencer W., Clare Bailey, José L. López-Ribot, et al.. (2001). Candida dubliniensis in radiation-induced oropharyngeal candidiasis. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 91(6). 659–662. 29 indexed citations

16.

Patterson, Thomas F., William R. Kirkpatrick, Mary H. White, et al.. (2000). Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes. Medicine. 79(4). 250–260. 576 indexed citations breakdown →

17.

Revankar, Sanjay G., Olga P. Dib, William R. Kirkpatrick, et al.. (1998). Clinical Evaluation and Microbiology of Oropharyngeal Infection Due to Fluconazole‐ResistantCandidain Human Immunodeficiency Virus–Infected Patients. Clinical Infectious Diseases. 26(4). 960–963. 56 indexed citations

18.

Revankar, Sanjay G., William R. Kirkpatrick, Olga P. Dib, et al.. (1996). Detection and Significance of Fluconazole Resistance in Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients. The Journal of Infectious Diseases. 174(4). 821–827. 88 indexed citations

19.

Kirkpatrick, William R., et al.. (1990). Monterey wastewater reclamation study for agriculture.. Journal of Water Pollution Control Federation. 62(3). 216–226. 29 indexed citations

20.

Smith, Roberts A. & William R. Kirkpatrick. (1980). Ribavirin, a broad spectrum antiviral agent. Academic Press eBooks. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact